Liver Injury Is Common Among Chronic Abusers of Ketamine

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 10, 2014, Pages 1759-1762.e1

  Wong, Grace Lai Hung ^a   Tam, Yuk Him ^a   Ng, Chi Fai ^a   Chan, Anthony Wing Hung ^a   Choi, Paul Cheung Lung ^a   Chu, Winnie Chiu Wing ^a   Lai, Paul Bo San ^a   Chan, Henry Lik Yuen ^a   Wong, Vincent Wai Sun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CBD; Clinical Report; Drug Abuse; Hepatobiliary Disease; Liver Damage; MRCP

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; KETAMINE;

ADULT; ARTICLE; BILE DUCT DILATATION; BILE DUCT INJURY; CHOLESTASIS; COMMON BILE DUCT; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; TOXIC HEPATITIS; URINARY TRACT DISEASE; ADDICTION; BILE DUCT; BIOPSY; COMPLICATION; CYTOCHEMISTRY; DRUG-INDUCED LIVER INJURY; LIVER; PATHOLOGY; PREVALENCE; RADIOGRAPHY; YOUNG ADULT;

ADULT; BILE DUCTS; BIOPSY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CROSS-SECTIONAL STUDIES; DRUG-INDUCED LIVER INJURY; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; KETAMINE; LIVER; MALE; PREVALENCE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84908101535     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.01.041     Document Type: Article

References (15)

1. Drug statistics, Central Registry of Drug Abuse fifty-ninth report, 2000-2009. HKSAR Narcotics Division, Security Bureau website. Available at: . Accessed August 15,2013. http://www.nd.gov.hk/text/en/stat/59_report.htm.
2. Lo R.S., Krishnamoorthy R., Freeman J.G., et al. Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series. Singapore Med J 2011, 52:e52-e55.
3. Noppers I.M., Niesters M., Aarts L.P., et al. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain 2011, 152:2173-2178.
4. Seto W.K., Ng M., Chan P., et al. Ketamine-induced cholangiopathy: a case report. Am J Gastroenterol 2011, 106:1004-1005.
5. Wong S.W., Lee K.F., Wong J., et al. Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. Hong Kong Med J 2009, 15:53-56.
6. Turkish A., Luo J.J., Lefkowitch J.H. Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis. Hepatology 2013, 58:825-827.
7. Danan G., Benichou C. Causality assessment of adverse reactions to drugs: I-a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. JClin Epidemiol 1993, 46:1323-1330.
8. Navarro V.J., Senior J.R. Drug-related hepatotoxicity. NEngl J Med 2006, 354:731-739.
9. Watkins P.B., Seeff L.B. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006, 43:618-631.
10. Rockey D.C., Seeff L.B., Rochon J., et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010, 51:2117-2126.
11. Goodman Z.D. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. JHepatol 2007, 47:598-607.
12. Griffin N., Yu D. Alexander Grant L. Magnetic resonance cholangiopancreatography: pearls, pitfalls, and pathology. Semin Ultrasound CT MR 2013, 34:32-43.
13. Lammert C., Einarsson S., Saha C., et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 2008, 47:2003-2009.
14. Jankovic S.M., Jankovic S.V., Stojadinovic D., et al. Effect of exogenous glutamate and N-methyl-D-aspartic acid on spontaneous activity of isolated human ureter. Int J Urol 2007, 14:833-837.
15. Liu C.Y., Liu J.Z., Zhou J.H., et al. TRH microinjection into DVC enhances motility of rabbits gallbladder via vagus nerve. World J Gastroenterol 1998, 4:162-164.